semaglutide synthetic peptide of the Week: Peptide: A Promising Advancement in Diabetes Treatment As demand for GLP-1 therapies

The first symptom of NAION is usually that one eye suddenly and painlessly goes blind as the optic nerve stops receiving enough blood

Tesamorelin UK research peptide guide from Astra Labs

Discover what current research reveals about GLP-1 receptor agonists and bone health, including evidence from clinical trials, risk factors to consider, and practical strategies to protect your skeletal health during treatment with semaglutide, liraglutide, and other GLP-1 therapies.

GLP-1 weight loss injections like Wegovy and Mounjaro are exploding in Ireland

Although, in the last 10 years, the use of GLP-1 RAs, especially semaglutide and liraglutide, has increased, its clinical implications and how it affects metabolic parameters have yet to be fully consolidated